The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children

International Journal of Obesity

Volumn 37, Issue 7, 2013, Pages 999-1005

  Wang, J ^a   Sun, B ^a   Hou, M ^a   Pan, X ^a   Li, X ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

11 HSD1; Adipogenesis; Adipose tissue; Bisphenol A; Children

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 4,4' ISOPROPYLIDENEDIPHENOL; CARBENOXOLONE; LIPOPROTEIN LIPASE; MESSENGER RNA; MIFEPRISTONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ABDOMINAL SURGERY; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADOLESCENT; ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID STORAGE; MALE; PERITONEAL BIOPSY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; SCHOOL CHILD;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOGENESIS; ADIPOSE TISSUE; ADOLESCENT; BENZHYDRYL COMPOUNDS; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; OBESITY; OMENTUM; PHENOLS; PPAR GAMMA; SUBCUTANEOUS TISSUE;

EID: 84880319382     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.173     Document Type: Article

References (41)

1. Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002; 8: 185-192.
2. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011; 127: 27-34.
3. Nam SH, Seo YM, Kim MG. Bisphenol A migration from polycarbonate baby bottle with repeated use. Chemosphere 2010; 79: 949-952.
4. Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118: 1055-1070.
5. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007; 24: 139-177.
6. Welshons WV, Nagel SC, Vom SF. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006; 147: S56-S69.
7. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008; 116: 39-44.
8. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, Vom SF. Exposure to bisphenol A advances puberty. Nature 1999; 401: 763-764.
9. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001; 109: 675-680.
10. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 2009; 117: 1549-1555.
11. Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 2002; 43: 676-684.
12. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84: 319-327.
13. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008; 116: 1642-1647.
14. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
15. Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W et al. Inhibition of 11Beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. J Clin Endocrinol Metab 2007; 92: 857-864.
16. Morton NM, Seckl Jr. 11Beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res 2008; 36: 146-164.
17. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002; 87: 3330-3336.
18. Munoz R, Carvajal C, Escalona A, Boza C, Perez G, Ibanez L et al. 11Betahydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients. Obes Surg 2009; 19: 764-770.
19. Li X, Lindquist S, Chen R, Myrnas T, Angsten G, Olsson T et al. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Int J Obes (Lond) 2007; 31: 820-828.
20. Wake DJ, Walker BR. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 in obesity. Endocrine 2006; 29: 101-108.
21. Zhu L, Hou M, Sun B, Buren J, Zhang L, Yi J et al. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depotspecific manner in children. J Clin Endocrinol Metab 2010; 95: 3300-3308.
22. Bujalska IJ, Quinkler M, Tomlinson JW, Montague CT, Smith DM, Stewart PM. Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes. J Mol Endocrinol 2006; 37: 327-340.
23. Spencer SJ, Tilbrook A. The glucocorticoid contribution to obesity. Stress 2011; 14: 233-246.
24. Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP. Body index measurements in 1996-7 compared with 1980. Arch Dis Child 2000; 82: 107-112.
25. Gesta S, Lolmede K, Daviaud D, Berlan M, Bouloumie A, Lafontan M et al. Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression. Horm Metab Res 2003; 35: 158-163.
26. Vankoningsloo S, Piens M, Lecocq C, Gilson A, De Pauw A, Renard P et al. Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid beta-oxidation and glucose. J Lipid Res 2005; 46: 1133-1149.
27. Pfaffl MW. A new mathematical model for relative quantification in real-time RTPCR. Nucleic Acids Res 2001; 29: e45.
28. Monder C, Lakshmi V, Miroff Y. Kinetic studies on rat liver 11 beta-hydroxysteroid dehydrogenase. Biochim Biophys Acta 1991; 1115: 23-29.
29. Walker EA, Clark AM, Hewison M, Ride JP, Stewart PM. Functional expression, characterization, and purification of the catalytic domain of human 11-beta - hydroxysteroid dehydrogenase type 1. J Biol Chem 2001; 276: 21343-21350.
30. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 2010; 18: 1283-1288.
31. Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N et al. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004; 141: 209-214.
32. Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med 2000; 62: 623-632.
33. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS et al. 11Beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25: 831-866.
34. Hutley LJ, Newell FM, Joyner JM, Suchting SJ, Herington AC, Cameron DP et al. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest 2003; 33: 574-581.
35. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y. PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 2003; 52: 291-299.
36. Pantoja C, Huff JT, Yamamoto KR. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol Biol Cell 2008; 19: 4032-4041.
37. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139: 4252-4263.
38. Gumy C, Chandsawangbhuwana C, Dzyakanchuk AA, Kratschmar DV, Baker ME, Odermatt A. Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine production. PLoS One 2008; 3: e3545.
39. Johansson M, Johansson N, Lund BO. Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells. Basic Clin Pharmacol Toxicol 2005; 96: 309-315.
40. Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V et al. In the search for specific inhibitors of human 11beta-hydroxysteroid- dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur J Endocrinol 2000; 142: 200-207.
41. Stewart PM. 11 Beta-hydroxysteroid dehydrogenase: implications for clinical medicine. Clin Endocrinol (Oxf) 1996; 44: 493-499. Institutions